Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk

Human Reproduction

Volumn 23, Issue 7, 2008, Pages 1661-1668

  Zhao, Zhen Zhen ^a   Pollock, Pamela M ^b   Thomas, Shane ^a   Treloar, Susan A ^a   Nyholt, Dale R ^a   Montgomery, Grant W ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Endometriosis; Fibroblast growth factor receptor 2; Haplotype; Single nucleotide polymorphism

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 44949118530     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den035     Document Type: Article

References (51)

1. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
2. Bertelsen L, Mellemkjaer L, Frederiksen K, Kjaer SK, Brinton LA, Sakoda LC, van Valkengoed I, Olsen JH. Risk for breast cancer among women with endometriosis. Int J Cancer 2007;120:1372-1375.
3. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572-579.
4. Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod 2001;16:1802-1808.
5. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-1093.
6. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005;16:139- 149.
7. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997;30:249-255.
8. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
9. Hadfield RM, Mardon HJ, Barlow DH, Kennedy SH. Endometriosis in monozygotic twins. Fertil Steril 1997;68:941-942.
10. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990;75:1023-1028.
11. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-874.
12. Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet 2004;13:69-78.
13. Jackson RJ. Cytoplasmic regulation of mRNA function: the importance of the 3′ untranslated region. Cell 1993;74:9-14.
14. Kennedy S, Mardon H, Barlow D. Familial endometriosis. J Assist Reprod Genet 1995;12:32-34.
15. Kondo T, Zheng L, Liu W, Kurebayashi J, Asa SL, Ezzat S. Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression. Cancer Res 2007;67:5461-5470.
16. Kurban G, Ishiwata T, Kudo M, Yokoyama M, Sugisaki Y, Naito Z. Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer. Oncol Rep 2004;11:987-991.
17. Lai EC. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002;30:363-364.
18. Li Y, Rinehart CA. Regulation of keratinocyte growth factor expression in human endometrium: implications for hormonal carcinogenesis. Mol Carcinog 1998;23:217-225.
19. Melin A, Sparen P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006;21:1237-1242.
20. Melin A, Sparen P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007;22:3021-3026.
21. Middeldorp A, Jagmohan-Changur S, Helmer Q, van der Klift HM, Tops CM, Vasen HF, Devilee P, Morreau H, Houwing-Duistermaat JJ, Wijnen JT et al. A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancer. BMC Cancer 2007;7:6.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
23. Moller B, Rasmussen C, Lindblom B, Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 2001;7:65-72.
24. Moskvina V, Holmans P, Schmidt KM, Craddock N. Design of case-controls studies with unscreened controls. Ann Hum Genet 2005;69:566-576.
25. Mostoufizadeh M, Scully RE. Malignant tumors arising in endometriosis. Clin Obstet Gynecol 1980;23:951-963.
26. Ness RB, Modugno F. Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers. Eur J Cancer 2006;42:691-703.
27. Nyholt DR. ssSNPer: identifying statistically similar SNPs to aid interpretation of genetic association studies. Bioinformatics 2006;22:2960-2961.
28. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001;2:REVIEWS3005.
29. Park S, Kim JH, Jang JH. Aberrant hypermethylation of the FGFR2 gene in human gastric cancer cell lines. Biochem Biophys Res Commun 2007;357:1011-1015.
30. Passos-Bueno MR, Wilcox WR, Jabs EW, Sertie AL, Alonso LG, Kitoh H. Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 1999;14:115-125.
31. Pekonen F, Nyman T, Rutanen EM. Differential expression of keratinocyte growth factor and its receptor in the human uterus. Mol Cell Endocrinol 1993;95:43-49.
32. Pollock PM, Gartside MG, Dejeza LC, Powell MA, Mallon MA, Davies H, Mohammadi M, Futreal PA, Stratton MR, Trent JM et al. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 2007;26:7158-7162.
33. Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, Yoshida T, Ferry G, Tucker G, Poupon MF, Chopin D et al. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene 1999;18:7234-7243.
34. Seidman JD. Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol 1996;15:1-9.
35. Siegfried S, Pekonen F, Nyman T, Ammala M. Expression of mRNA for keratinocyte growth factor and its receptor in human endometrium. Acta Obstet Gynecol Scand 1995;74:410-414.
36. Siegfried S, Pekonen F, Nyman T, Ammala M, Rutanen EM. Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma. Cancer 1997;79:1166-1171.
37. Simpson JL, Bischoff FZ. Heritability and molecular genetic studies of endometriosis. Ann N Y Acad Sci 2002;955:239-251; discussion 293-235, 396-406.
38. Stefansson H, Geirsson RT, Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, Ingadottir G, Gulcher J, Stefansson K. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod 2002;17:555-559.
39. Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci 2002;955:281-292; discussion 293-285, 396-406.
40. Taniguchi F, Harada T, Ito M, Yoshida S, Iwabe T, Tanikawa M, Terakawa N. Keratinocyte growth factor in the promotion of human chorionic gonadotropin production in human choriocarcinoma cells. Am J Obstet Gynecol 2000;182:692-698.
41. The American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985;43:351-352.
42. Treloar SA, Do KA, O'Connor VM, O'Connor DT, Yeo MA, Martin NG. Predictors of hysterectomy: an Australian study. Am J Obstet Gynecol 1999;180:945-954.
43. Treloar S, Hadfield R, Montgomery G, Lambert A, Wicks J, Barlow DH, O'Connor DT, Kennedy S. The International Endogene Study: a collection of families for genetic research in endometriosis. Fertil Steril 2002;78:679-685.
44. Treloar SA, Wicks J, Nyholt DR, Montgomery GW, Bahlo M, Smith V, Dawson G, Mackay IJ, Weeks DE, Bennett ST et al. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 2005;77:365-376.
45. Visco V, Carico E, Marchese C, Torrisi MR, Frati L, Vecchione A, Muraro R. Expression of keratinocyte growth factor receptor compared with that of epidermal growth factor receptor and erbB-2 in endometrial adenocarcinoma. Int J Oncol 1999;15:431-435.
46. Wilkie AO, Patey SJ, Kan SH, van den Ouweland AM, Hamel BC. FGFs, their receptors, and human limb malformations: clinical and molecular correlations. Am J Med Genet 2002;112:266-278.
47. Yasumoto H, Matsubara A, Mutaguchi K, Usui T, McKeehan WL. Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells. Prostate 2004;61:236-242.
48. Zhang Y, Wang H, Toratani S, Sato JD, Kan M, McKeehan WL, Okamoto T. Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc Natl Acad Sci USA 2001;98:11336-11340.
49. Zhao ZZ, Nyholt DR, Le L, Martin NG, James MR, Treloar SA, Montgomery GW. KRAS variation and risk of endometriosis. Mol Hum Reprod 2006;12:671-676.
50. Zhao ZZ, Nyholt DR, Le L, Thomas S, Engwerda C, Randall L, Treloar SA, Montgomery GW. Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample. Hum Reprod 2007;22:2389-2397.
51. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 2002;17:1415-1423.